IN8BIO, INC. — Director's Dealing 2022

Jun 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2022-06-01

Reporting Person: Roemer Alan S. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-01	Stock Option (right to buy)	$2.24	A	10500	Acquired	2032-06-01	Common Stock (10500)	Direct

Footnotes

F1: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date.